tiprankstipranks
Trending News
More News >

Charmacy Pharmaceutical Announces Final Dividend for 2024

Story Highlights
Charmacy Pharmaceutical Announces Final Dividend for 2024

Confident Investing Starts Here:

Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) has issued an announcement.

Charmacy Pharmaceutical Co., Ltd. has announced a final cash dividend of RMB 0.45 per share for the year ending December 31, 2024, with shareholder approval scheduled for May 22, 2025. The dividend payment is set for July 11, 2025, and will involve withholding tax rates of 10% for non-resident enterprises and individuals, and 20% for resident individuals, impacting stakeholders based on their residency status.

More about Charmacy Pharmaceutical Co., Ltd. Class H

Charmacy Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the distribution and sale of pharmaceutical products. The company primarily serves the healthcare sector, offering a range of medicinal products to meet market demands.

YTD Price Performance: -20.92%

Average Trading Volume: 2,000

Technical Sentiment Signal: Buy

Current Market Cap: HK$837M

For an in-depth examination of 2289 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1